{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:54:45Z","timestamp":1779890085316,"version":"3.53.1"},"reference-count":35,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705300"],"award-info":[{"award-number":["2022YFC2705300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is widespread worldwide, and a strong link between MASLD and cardiometabolic risk factors (CMRFs) was highlighted in this study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study characterized the prevalence of MASLD in adolescent population and overlapping CMRFs conditions in MASLD.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is a cross-sectional study of US adolescents aged 12 to 19 years in the 2017 through 2020 cycles of the National Health and Nutrition Examination Survey. The relationship between CMRFs and liver steatosis, evaluated by the median controlled attenuation parameter (CAP), was assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The prevalence of MASLD in adolescents was 23.77%. Isolated overweight\/obesity (35%) was the top CMRF. Non-Hispanic Black patients had the highest proportion of overweight\/obesity plus elevated glucose (24%), whereas non-Hispanic Asians had the highest burden of dyslipidemia (2%, 14%, and 19%). Except for hypertension, overweight\/obesity (\u03b2 = 48.7; 95% CI, 43.4-54.0), hypertriglyceridemia (\u03b2 = 15.5; 95% CI, 7.2-28.3), low HDL-C (\u03b2 = 10.0; 95% CI, 3.1-16.9), elevated glucose (\u03b2 = 6.9; 95% CI, 0.6-13.2) were all significantly associated with increased CAP values. Increased CAP was linked to the synergistic interactions between overweight\/obesity and dyslipidemia or elevated glucose (overweight\/obesity and elevated glucose: relative excess risk due to interaction [RERI] = 8.21, attributable proportion due to interaction [AP] = 0.45, synergy index [SI] = 1.91; overweight\/obesity and hypertriglyceridemia: RERI = 19.00, AP = 0.69, SI = 3.53; overweight\/obesity and low high-density lipoprotein cholesterol: RERI = 10.83, AP = 0.58, SI = 2.61). Adolescents with combination of overweight\/obesity, dyslipidemia (\u03b2 = 15.1; 95% CI, 0.1-30.2) and combination of overweight\/obesity, dyslipidemia and elevated glucose (\u03b2 = 48.0; 95% CI, 23.3-72.6) had a significantly higher CAP values.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>The prevalence of MASLD was alarmingly high in adolescents, and overweight\/obesity was the most important CMRF. Overweight\/obesity and dyslipidemia or elevated glucose had positive additive interaction effects on liver steatosis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae553","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T11:07:20Z","timestamp":1723547240000},"page":"e1458-e1465","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of Metabolic Dysfunction-associated Steatotic Liver Disease and Cardiometabolic Risk Factor in US Adolescents"],"prefix":"10.1210","volume":"110","author":[{"given":"Xiaoyan","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongying","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nursing, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9985-5134","authenticated-orcid":false,"given":"Yan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9326-1012","authenticated-orcid":false,"given":"Yongjun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine , Shanghai 200092 ,","place":["China"]},{"name":"Shanghai Institute for Pediatric Research, Shanghai Jiao Tong University School of Medicine, Xinhua Hospital , Shanghai 200092 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"issue":"9","key":"2025042208272821300_dgae553-B1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/s41575-019-0169-z","article-title":"NAFLD in children: new genes, new diagnostic modalities and new drugs","volume":"16","author":"Nobili","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"2025042208272821300_dgae553-B2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/gutjnl-2022-328105","article-title":"Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease","volume":"72","author":"Simon","year":"2023","journal-title":"Gut"},{"issue":"1","key":"2025042208272821300_dgae553-B3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/hep.31018","article-title":"Liver fat and cardiometabolic risk factors among school-age children","volume":"72","author":"Geurtsen","year":"2020","journal-title":"Hepatology"},{"issue":"6","key":"2025042208272821300_dgae553-B4","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"2025042208272821300_dgae553-B5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.mayocp.2016.09.017","article-title":"Review of childhood obesity: from epidemiology, etiology, and comorbidities to clinical assessment and treatment","volume":"92","author":"Kumar","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"14","key":"2025042208272821300_dgae553-B6","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1502821","article-title":"Cardiometabolic risks and severity of obesity in children and young adults","volume":"373","author":"Skinner","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"2025042208272821300_dgae553-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12933-020-01052-1","article-title":"Cardiovascular morbidity, diabetes and cancer risk among children and adolescents with severe obesity","volume":"19","author":"Bendor","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"2025042208272821300_dgae553-B8","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1111\/dom.14834","article-title":"Increased prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes and hypertension: the SWEET international database","volume":"24","author":"Vazeou","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"2","key":"2025042208272821300_dgae553-B9","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/j.jhep.2023.09.030","article-title":"The influence of different combinations of cardiometabolic risk factors on the prevalence of MASLD and risk of advanced fibrosis deserves attention","volume":"80","author":"Yang","year":"2024","journal-title":"J Hepatol"},{"issue":"6","key":"2025042208272821300_dgae553-B10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/obr.12407","article-title":"Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies","volume":"17","author":"Li","year":"2016","journal-title":"Obes Rev"},{"key":"2025042208272821300_dgae553-B11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J Pediatr"},{"issue":"10","key":"2025042208272821300_dgae553-B12","doi-asserted-by":"crossref","first-page":"e161971","DOI":"10.1001\/jamapediatrics.2016.1971","article-title":"Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease","volume":"170","author":"Newton","year":"2016","journal-title":"JAMA Pediatr"},{"key":"2025042208272821300_dgae553-B13","author":"Centers for Disease Control and Prevention"},{"key":"2025042208272821300_dgae553-B14","author":"Centers for Disease Control and Prevention"},{"issue":"10","key":"2025042208272821300_dgae553-B15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","article-title":"Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement","volume":"6","author":"Eslam","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"2025042208272821300_dgae553-B16","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jhep.2016.12.022","article-title":"Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis","volume":"66","author":"Karlas","year":"2017","journal-title":"J Hepatol"},{"issue":"2","key":"2025042208272821300_dgae553-B17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hep.22376","article-title":"Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis","volume":"48","author":"Nobili","year":"2008","journal-title":"Hepatology"},{"issue":"3","key":"2025042208272821300_dgae553-B18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1542\/peds.2012-2328","article-title":"US prevalence and trends in tobacco smoke exposure among children and adolescents with asthma","volume":"131","author":"Kit","year":"2013","journal-title":"Pediatrics"},{"issue":"7","key":"2025042208272821300_dgae553-B19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","article-title":"Calculating measures of biological interaction","volume":"20","author":"Andersson","year":"2005","journal-title":"Eur J Epidemiol"},{"key":"2025042208272821300_dgae553-B20","unstructured":"Zheng X . 2024. Supplemental_Materials_Zheng_et_al. Figshare. doi:10.6084\/m9.figshare.25557342.v4. Date of deposit 20 July 2024."},{"issue":"2","key":"2025042208272821300_dgae553-B21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jpn3.12230","article-title":"Fibrosis and steatotic liver disease in US adolescents according to the new nomenclature","volume":"79","author":"Ma","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"2025042208272821300_dgae553-B22","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jpn3.12219","article-title":"The prevalence and predictors of metabolic dysfunction-associated steatotic liver disease and fibrosis\/cirrhosis among adolescents\/young adults","volume":"79","author":"Perumpail","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"11","key":"2025042208272821300_dgae553-B23","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1210\/clinem\/dgaa574","article-title":"Sex hormone relations to histologic severity of pediatric nonalcoholic fatty liver disease","volume":"105","author":"Mueller","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025042208272821300_dgae553-B24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hep.30804","article-title":"Childhood socioeconomic disadvantage and risk of fatty liver in adulthood: the cardiovascular risk in Young Finns Study","volume":"71","author":"Laitinen","year":"2020","journal-title":"Hepatology"},{"issue":"10113","key":"2025042208272821300_dgae553-B25","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"2025042208272821300_dgae553-B26","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"issue":"6","key":"2025042208272821300_dgae553-B27","first-page":"853","article-title":"Most overweight and obese Indian children have nonalcoholic fatty liver disease","volume":"15","author":"Pawar","year":"2016","journal-title":"Ann Hepatol"},{"issue":"6","key":"2025042208272821300_dgae553-B28","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3748\/wjg.v17.i6.735","article-title":"Non-alcoholic fatty liver disease: an early mediator predicting metabolic syndrome in obese children?","volume":"17","author":"Fu","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"5","key":"2025042208272821300_dgae553-B29","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","article-title":"Progression of fatty liver disease in children receiving standard of care lifestyle advice","volume":"159","author":"Xanthakos","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"2025042208272821300_dgae553-B30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.30035","article-title":"Metabolic features of Nonalcoholic Fatty Liver (NAFL) in obese adolescents: findings from a multiethnic cohort","volume":"68","author":"Tric\u00f2","year":"2018","journal-title":"Hepatology"},{"issue":"8","key":"2025042208272821300_dgae553-B31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2022.12567","article-title":"Trends in lipid concentrations and lipid control among US adults, 2007\u20132018","volume":"328","author":"Aggarwal","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"2025042208272821300_dgae553-B32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2468-1253(19)30419-4","article-title":"Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study","volume":"5","author":"Abeysekera","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"2025042208272821300_dgae553-B33","doi-asserted-by":"crossref","first-page":"e0220612","DOI":"10.1371\/journal.pone.0220612","article-title":"Increasing metabolic co-morbidities are associated with higher risk of advanced fibrosis in nonalcoholic steatohepatitis","volume":"14","author":"Wong","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"2025042208272821300_dgae553-B34","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1111\/liv.14675","article-title":"MAFLD identifies patients with significant hepatic fibrosis better than NAFLD","volume":"40","author":"Yamamura","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"2025042208272821300_dgae553-B35","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/jpn3.12124","article-title":"Pediatricians\u2019 practices and knowledge of metabolic dysfunction-associated steatotic liver disease: an international survey","volume":"78","author":"Lubrecht","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae553\/58953308\/dgae553.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/5\/e1458\/58953308\/dgae553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/5\/e1458\/58953308\/dgae553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T12:27:54Z","timestamp":1745324874000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/5\/e1458\/7732379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,13]]},"published-print":{"date-parts":[[2025,4,22]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae553","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,8,13]]}}}